glp-1 receptor agonist structure Effects of Replacing a Central Glycine Residue in GLP‐1 on Affinity and Signaling Profile - Brown - 2023 - ChemBioChem How GLP-1 Receptor Agonists Evolved
Description
Important context: the FDA has warned that retatrutide is not a component of an FDA-approved drug and has not been found safe/effective for any condition
Many of the patients I see suffer from severe kidney complications and comorbidities, with some needing dialysis
The litigation focuses on claims that GLP-1 RA drugs may cause a rare eye condition called non-arteritic anterior ischemic optic neuropathy (NAION)
Contact of nutrients with L-cells in the distal gut likely explains the prolonged duration of elevated GLP-1 during meals, and it might also be responsible for the typically observed increased levels of GLP-1 following gastric bypass and, albeit less so, after sleeve gastrectomy surgery [[211], [212], [213], [214], [215], [216]], because surgical repositioning of the distal gut more rapidly exposes the distal L-cells to incoming nutrients [144]
Boutant M, Joffraud M, Kulkarni SS, Garcia-Casarrubios E, Garcia-Roves PM, Ratajczak J, et al
GLP-1 Agonists: The Latest Obesity Long-Term Use Data MedCentral
